Flather, M.

patient trial disease artery study treatment surgery death revascularization graft angioplasty stent randomized artery disease outcome diabetes follow-up multivessel result group mortality analysis survival infarction characteristic ita graft intervention hazard ratio percutaneou multivessel disease hazard effect baseline vessel patient data end point heart circulation ratio stroke table swets subs service randomised trials randomised coll cardiol baseline characteristics stenting 5 years drug-eluting stents point model treatment effect angina thoracic cabg group signi pci group e ffect number meta-analysi safety cardiol score propensity method signi ficantly interaction subgroups 4 randomized trials event 3- vessel disease propensity score e ffectiveness heterogeneity fidence interval drug-eluting bare-metal angioplasty revascularization investigation figure revascularization therapies study